Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Ann Neurol. 2010 Feb;67(2):159–169. doi: 10.1002/ana.21886

Table 2.

Correlations between viral IgG titers and clinical and brain MRI parameters

Baseline
1 year1
5 years2
Serologies BC NT2L NT2L NNT2L EDSS NT2L NNT2L EDSS
Measles −0.02 (0.796) −0.02 (0.799) 0.05 (0.595) 0.01 (0.876) 0.08 (0.372) −0.01 (0.926) −0.01 (0.961) 0.02 (0.859)
HCMV −0.06 (0.455) 0.03 (0.728) 0.02 (0.801) 0.01 (0.950) 0.07 (0.403) 0.01 (0.946) −0.03 (0.767) 0.12 (0.197)
HHV-6 −0.06 (0.473) −0.05 (0.559) 0.05 (0.633) −0.01 (0.969) 0.17 (0.044) 0.13 (0.219) 0.14 (0.182) −0.01 (0.962)
EBV-VCA 0.22 (0.009) 0.27 (0.002) 0.21 (0.020) 0.12 (0.161) 0.15 (0.085) 0.18 (0.077) 0.08 (0.438) 0.14 (0.152)
 -EBNA1 0.30 (0.001) 0.24 (0.006) 0.24 (0.012) 0.22 (0.012) 0.21 (0.015) 0.31 (0.003) 0.23 (0.028) 0.25 (0.010)
 -EA −0.01 (0.979) −0.01 (0.957) −0.15 (0.501) −0.15 (0.478) 0.08 (0.696) 0.16 (0.547) 0.04 (0.888) −0.19 (0.400)

Data are expressed as Spearman correlation coefficient (p value).

1

Number of patients with 1 year follow-up: 147.

2

Number of patients with 5 year follow-up: 119. HCMV: cytomegalovirus. HHV-6: human herpesvirus 6. EBV: Epstein-Barr virus. VCA: viral capsid antigen. EBNA1: EBV nuclear antigen 1. EA: early antigen. BC: Barkhof criteria. NT2L: number of T2 lesions. NNT2L: number of new T2 lesions. EDSS: Expanded Disability Status Scale.